絞り込み

16532

広告

EGFR Mutation is Associated with Short Progression Free Survival in Patients with Stage III Non-Squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.

著者 Park SE , Noh JM , Kim YJ , Lee HS , Cho JH , Lim SW , Ahn YC , Pyo H , Choi YL , Han J , Sun JM , Lee SH , Ahn JS , Park K , Ahn MJ
Cancer Res Treat.2018 Jun 18 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (18view , 1users)

Full Text Sources

Miscellaneous

This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT).
PMID: 29914238 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード